文献速递银屑病与炎症性皮肤病

银屑病炎症转录组特征与未来心血管事件相关

An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2023-03-22

研究对37例无心血管疾病的银屑病患者和11名匹配对照进行全血RNA测序,并在两个心血管疾病队列中验证该转录组特征。银屑病诊断和严重程度相关的全血转录组特征与现患心肌梗死及新发主要不良心血管或肢体事件相关。

要点

  • 银屑病患者全血中247个基因上调、228个基因下调,1302个基因与PASI正相关、1244个基因与PASI负相关。
  • 银屑病与PASI重叠的73个基因中,50个(68%)与现患心肌梗死相关,29个(40%)与新发MACLE相关。
  • 关键调控因子包括IL-6、IL-1β、干扰素γ以及SOCS3、BCL3、OSM、PIM2、PIM3和STAT5A。

核心结论

  • 银屑病诊断和严重程度相关的全血转录组特征与现患心肌梗死及新发主要不良心血管或肢体事件相关。

研究设计与样本

  • 研究纳入37例有中重度皮肤病史但无心血管疾病的银屑病患者和11名匹配对照,进行全血RNA测序。
  • 该转录组特征在两个心血管疾病队列中评估:因心脏导管检查转诊的女性中有心肌梗死76例 versus 无心肌梗死97例,以及外周动脉疾病患者106例随访2.5年观察主要不良心血管或肢体事件。

主要发现

  • 银屑病患者中位年龄44岁(IQR 34-51),49%为男性,ACC/AHA ASCVD风险评分为1.0%(0.6-3.4),与对照相比无显著差异。
  • 银屑病患者中位PASI评分为4.0(IQR 2.9-8.2),36%接受生物制剂治疗。
  • 银屑病与对照相比,全血中247个基因上调、228个基因下调(p < 0.05),1302个基因与PASI正相关、1244个基因与PASI负相关(p < 0.05)。
  • 银屑病与PASI之间有73个基因重叠,关键调控因子为IL-6、IL-1β和干扰素γ。
  • 在心血管疾病队列中,银屑病识别的73个基因中有50个(68%)与现患心肌梗死相关,29个(40%)与新发MACLE相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is an inflammatory skin disease associated with increased cardiovascular (CV) risk, whose pathogenesis is not fully known. OBJECTIVE: We identified a transcriptomic signature in psoriasis and investigated its association with prevalent and future risk of a CV event to understand the connection between psoriasis and CV disease (CVD). METHODS: Psoriasis patients (n = 37) with a history of moderate-severe skin disease without CVD and 11 matched controls underwent whole blood RNA sequencing. This transcriptomic signature in psoriasis versus controls was evaluated in two CVD cohorts: Women referred for cardiac catheterization with (n = 76) versus without (n = 97) myocardial infarction (MI), and patients with peripheral artery disease (n = 106) followed over 2.5 years for major adverse CV or limb events (MACLE). The association between genes differentially expressed in psoriasis and prevalent and incident CV events was assed. RESULTS: In psoriasis, median age was 44 (IQR; 34-51) years, 49% male and ACC/AHA ASCVD Risk Score of 1.0% (0.6-3.4) with no significant difference versus controls. The median psoriasis area and severity index score (PASI) was 4.0 (IQR 2.9-8.2) with 36% on biologic therapy. Overall, 247 whole blood genes were upregulated and 228 downregulated in psoriasis versus controls (p < 0.05), and 1302 genes positively and 1244 genes negatively correlated with PASI (p < 0.05). Seventy-three genes overlapped between psoriasis prevalence and PASI with key regulators identified as IL-6, IL-1β and interferon gamma. In the CVD cohorts, 50 of 73 genes (68%) identified in psoriasis associated with prevalent MI, and 29 (40%) with incident MACLE. Key regulator transcripts identified in psoriasis and CVD cohorts included SOCS3, BCL3, OSM, PIM2, PIM3 and STAT5A. CONCLUSIONS: A whole blood transcriptomic signature of psoriasis diagnosis and severity associated with prevalent MI and incident MACLE. These data have implications for better understanding the link between psoriasis, systemic inflammation and CVD.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Garshick MS, Barrett TJ, Cornwell MG, et al. An inflammatory transcriptomic signature in psoriasis associates with future cardiovascular events. J Eur Acad Dermatol Venereol. 2023. PMID: 36924033. doi:10.1111/jdv.19049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。